Tatum Anderson

Journalist, writer and editor

I have been writing science, technology, international development, business and travel articles for almost 20 years.

Global health Is my main focus and I've written for newspapers, science, business and medical publications from The Lancet to The Economist, British Medical Journal, BBC News, Guardian Weekly and Nature.

My articles have also appeared in publications produced by the Department for International Development (DFID) and the World Health Organisation (WHO).

I am available for freelance commissions and can produce features, white papers, supplements, short reports and copy for internal magazines and websites.

Portfolio

Israel's proposed medical tourism legislation
20 February 2017 Tatum Anderson investigates how a new bill from the Ministries of Health and Tourism seeks to improve treatment for Israeli patients It's not just the...
Trip into the unknown
News: Business A plant in Uganda hopes to sell cut-price drugs by taking advantage of exemptions from rules that protect patents. But its operators face major obstacles, as...
The politics of pain
Pain relief is often taken for granted in the Western world, but in about 150 countries the use of morphine is severely restricted. Tatum Anderson investigates how this has come...
From palm leaf to database
Thousands of medical treatments contained in these texts are used extensively in India, particularly in rural areas. The texts are trusted by patients because they were written...
Africa hails new meningitis vaccine - BBC News
For the people in Niger, Mali and Burkina Faso, a new meningitis vaccine offers hope of an escape from one of the world's deadliest, most disabling and infectious diseases. So...
Countries mull over incentives for developing antibiotics
Governments are considering which financial incentives will be the best to boost research and development for much needed new antibiotic drugs. Tatum Anderson reports.
Curbing prescription opioid dependency
The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP - Intellectual...
by for Intellectual Property Watch With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to...
Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? - Intellectual...
The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as...
Polypills: Are Miracle Treatments Being Overlooked? - Intellectual Property Watch
Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world's number one killer, accounting for one-third of deaths...
Doctors lobby for better chronic pain management
Several campaigns and initiatives are underway in Europe and the USA by doctors hoping to improve services and care for patients with chronic pain. Tatum Anderson reports.
Beyond the horizon A look into centres of medical excellence opening ‘outposts’ in different...
A look into centres of medical excellence opening ‘outposts’ in different countries
Can open-source drug development deliver?
Open-source drug development involves open data sharing, collaboration, and results sharing. The aim is to produce new drugs for neglected diseases. But can it work? Tatum...
A question of transparency
13 October 2016 Tatum Anderson looks at global efforts to enhance hospital pricing transparency In March this year, a group of 11 organisations - including one that represents...
Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise -...
by for Intellectual Property Watch Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is...
Paediatric Cancer Drug Being Developed Entirely In The Open - Intellectual Property Watch
The term "Open" in science is all the rage these days. The Medicines for Malaria Venture (MMV) has posted a Malaria Box, containing over 400 compounds that might be effective...
EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing Countries - Intellectual Property...
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive...

All Copyrights Belong To Their Respective Owners